These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14701846)

  • 21. Resolution of tryptophan-ANS fluorescence energy transfer in apomyoglobin by site-directed mutagenesis.
    Sirangelo I; Malmo C; Casillo M; Irace G
    Photochem Photobiol; 2002 Oct; 76(4):381-4. PubMed ID: 12405143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the interactions of fluorescent probes with proteins: coumarin 153 and 1,8-ANS in complex with holo- and apomyoglobin.
    Mukherjee P; Halder M; Hargrove MS; Petrich JW
    Photochem Photobiol; 2006; 82(6):1586-90. PubMed ID: 16961435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of H helix destabilizing mutations on the kinetic and equilibrium folding of apomyoglobin.
    Cavagnero S; Dyson HJ; Wright PE
    J Mol Biol; 1999 Jan; 285(1):269-82. PubMed ID: 9878405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of ANS binding to tuna apomyoglobin measured with fluorescence correlation spectroscopy.
    Bismuto E; Gratton E; Lamb DC
    Biophys J; 2001 Dec; 81(6):3510-21. PubMed ID: 11721012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperativity of folding of the apomyoglobin pH 4 intermediate studied by glycine and proline mutations.
    Luo Y; Kay MS; Baldwin RL
    Nat Struct Biol; 1997 Nov; 4(11):925-30. PubMed ID: 9360609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kinetics of interaction between apomyoglobin and phospholipid membrane].
    Balobanov VA; Il'ina NB; Katina NS; Kashparov IA; Dolgikh DA; Bychkova VE
    Mol Biol (Mosk); 2010; 44(4):708-17. PubMed ID: 20873231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early events in the fibrillation of monomeric insulin.
    Ahmad A; Uversky VN; Hong D; Fink AL
    J Biol Chem; 2005 Dec; 280(52):42669-75. PubMed ID: 16246845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the apomyoglobin folding pathway caused by mutation of the distal histidine residue.
    Garcia C; Nishimura C; Cavagnero S; Dyson HJ; Wright PE
    Biochemistry; 2000 Sep; 39(37):11227-37. PubMed ID: 10985768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate.
    Sirangelo I; Bismuto E; Tavassi S; Irace G
    Biochim Biophys Acta; 1998 Jun; 1385(1):69-77. PubMed ID: 9630524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights on the structure of amyloid fibrils from site-directed mutagenesis.
    Corrêa DH; Ramos CH
    Protein Pept Lett; 2009; 16(12):1519-25. PubMed ID: 20001915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrillogenesis of apomyoglobin facilitated by aggregation sequence of yeast Sup35 in various regions.
    He Y; Tang H; Yi Z; Zhou H; Luo Y
    FEBS Lett; 2005 Feb; 579(6):1503-8. PubMed ID: 15733864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational and dynamic characterization of the molten globule state of an apomyoglobin mutant with an altered folding pathway.
    Cavagnero S; Nishimura C; Schwarzinger S; Dyson HJ; Wright PE
    Biochemistry; 2001 Dec; 40(48):14459-67. PubMed ID: 11724558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pressure-induced perturbation of ANS-apomyoglobin complex: frequency domain fluorescence studies on native and acidic compact states.
    Bismuto E; Irace G; Sirangelo I; Gratton E
    Protein Sci; 1996 Jan; 5(1):121-6. PubMed ID: 8771204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
    Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW
    J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agitation and high ionic strength induce amyloidogenesis of a folded PDZ domain in native conditions.
    Sicorello A; Torrassa S; Soldi G; Gianni S; Travaglini-Allocatelli C; Taddei N; Relini A; Chiti F
    Biophys J; 2009 Mar; 96(6):2289-98. PubMed ID: 19289055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Packing interactions in the apomyglobin folding intermediate.
    Kay MS; Baldwin RL
    Nat Struct Biol; 1996 May; 3(5):439-45. PubMed ID: 8612074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Misfolding and amyloid aggregation of apomyoglobin.
    Iannuzzi C; Maritato R; Irace G; Sirangelo I
    Int J Mol Sci; 2013 Jul; 14(7):14287-300. PubMed ID: 23839096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heme binding site in apomyoglobin may be effectively targeted with small molecules to control aggregation.
    Azami-Movahed M; Shariatizi S; Sabbaghian M; Ghasemi A; Ebrahim-Habibi A; Nemat-Gorgani M
    Int J Biochem Cell Biol; 2013 Feb; 45(2):299-307. PubMed ID: 23089873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of apomyoglobin with membranes: mechanisms and effects on heme uptake.
    Vernier G; Chenal A; Vitrac H; Barumandzadhe R; Montagner C; Forge V
    Protein Sci; 2007 Mar; 16(3):391-400. PubMed ID: 17242377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pressure-induced perturbation of apomyoglobin structure: fluorescence studies on native and acidic compact forms.
    Bismuto E; Sirangelo I; Irace G; Gratton E
    Biochemistry; 1996 Jan; 35(4):1173-8. PubMed ID: 8573571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.